New AXA Chair in Cardiovascular Risk in Women During Menopause Granted with 1M€ in Seville




2mins | News

 The funds will finance Inés Pineda Torra's research at the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) for five years. 

The AXA Research Fund’s scientific board has awarded a one-million-euro Chair to Inés Pineda Torra, Distinguished Principal Investigator at the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER). Pineda's goal in this project is to more effectively profile cardiovascular risk in women, which increases with menopause, and to define how hormonal changes and circulating fats that appear with menopause influence the molecular mechanisms that explain this risk. Her group will investigate variations in circulating fat levels, as well as gene and protein expression profiles, and will establish whether there are differences with men in the key processes identified. 

Defining the molecular basis of the increased cardiovascular risk in women with menopause will help prevent it, identifying new biomarkers to improve current prediction and diagnosis tools, as well as identifying possible therapeutic targets. 

Cardiovascular diseases, traditionally considered men's diseases, are also the leading cause of death among women worldwide, ahead of others more associated with them such as breast cancer or osteoporosis. Despite this, women continue to be under-studied in research. This highlights the importance of the project that Inés Pineda Torra is going to lead, and to which we at AXA are going to give her all our support.

Olga Sánchez CEO of AXA Spain

Pineda Torra is an internationally renowned expert in lipid metabolism in a cardiometabolic context, with more than two decades of experience in the regulation of nuclear, hormonal receptors and high-performance techniques. In April 2022, she moved to CABIMER in Seville, hired by the Progress and Health Foundation. She is also an Honorary Professor of Cardiometabolic Medicine at University College London, where until her arrival in Andalusia she led the Lipid Metabolism and Immunity Group in the Department of Medicine at that university. She currently leads the research group on Metabolism, Immunology and Cardiovascular Risk, as well as the Department of Integrative Pathophysiology and Therapies at the Seville center. Her research aims to understand the connection between metabolic and immune pathways and understand how they influence the development and progression of metabolic and cardiovascular diseases. 

February 2024

Understanding Menopause's Effect on Women's Cardiovascular Risk

Click below to find out more about Inés Pineda-Torra's research project. 

Learn more